Biochemistry

  1. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking

    1. Marion Schuller
    2. Galen J. Correy
    3. Stefan Gahbauer
    4. Daren Fearon
    5. Taiasean Wu
    6. Roberto Efraín Díaz
    7. Iris D. Young
    8. Luan Carvalho Martins
    9. Dominique H. Smith
    10. Ursula Schulze-Gahmen
    11. Tristan W. Owens
    12. Ishan Deshpande
    13. Gregory E. Merz
    14. Aye C. Thwin
    15. Justin T. Biel
    16. Jessica K. Peters
    17. Michelle Moritz
    18. Nadia Herrera
    19. Huong T. Kratochvil
    20. QCRG Structural Biology Consortium
    21. Anthony Aimon
    22. James M. Bennett
    23. Jose Brandao Neto
    24. Aina E. Cohen
    25. Alexandre Dias
    26. Alice Douangamath
    27. Louise Dunnett
    28. Oleg Fedorov
    29. Matteo P. Ferla
    30. Martin R. Fuchs
    31. Tyler J. Gorrie-Stone
    32. James M. Holton
    33. Michael G. Johnson
    34. Tobias Krojer
    35. George Meigs
    36. Ailsa J. Powell
    37. Johannes Gregor Matthias Rack
    38. Victor L. Rangel
    39. Silvia Russi
    40. Rachael E. Skyner
    41. Clyde A. Smith
    42. Alexei S. Soares
    43. Jennifer L. Wierman
    44. Kang Zhu
    45. Peter O’Brien
    46. Natalia Jura
    47. Alan Ashworth
    48. John J. Irwin
    49. Michael C. Thompson
    50. Jason E. Gestwicki
    51. Frank von Delft
    52. Brian K. Shoichet
    53. James S. Fraser
    54. Ivan Ahel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Structural impact on SARS-CoV-2 spike protein by D614G substitution

    1. Jun Zhang
    2. Yongfei Cai
    3. Tianshu Xiao
    4. Jianming Lu
    5. Hanqin Peng
    6. Sarah M. Sterling
    7. Richard M. Walsh
    8. Sophia Rits-Volloch
    9. Haisun Zhu
    10. Alec N. Woosley
    11. Wei Yang
    12. Piotr Sliz
    13. Bing Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors

    1. Chunlong Ma
    2. Yanmei Hu
    3. Julia Alma Townsend
    4. Panagiotis I. Lagarias
    5. Michael Thomas Marty
    6. Antonios Kolocouris
    7. Jun Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition

    1. Takamitsu Hattori
    2. Akiko Koide
    3. Maria G. Noval
    4. Tatyana Panchenko
    5. Larizbeth A. Romero
    6. Kai Wen Teng
    7. Takuya Tada
    8. Nathaniel R. Landau
    9. Kenneth A. Stapleford
    10. Shohei Koide

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2

    1. Brian J. Conti
    2. Andrew S. Leicht
    3. Robert N. Kirchdoerfer
    4. Michael R. Sussman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors

    1. Kai S. Yang
    2. Xinyu R. Ma
    3. Yuying Ma
    4. Yugendar R. Alugubelli
    5. Danielle A. Scott
    6. Erol C. Vatansever
    7. Aleksandra K. Drelich
    8. Banumathi Sankaran
    9. Zhi Z. Geng
    10. Lauren R. Blankenship
    11. Hannah E. Ward
    12. Yan J. Sheng
    13. Jason C. Hsu
    14. Kaci C. Kratch
    15. Baoyu Zhao
    16. Hamed S. Hayatshahi
    17. Jin Liu
    18. Pingwei Li
    19. Carol A. Fierke
    20. Chien-Te K. Tseng
    21. Shiqing Xu
    22. Wenshe Ray Liu

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  7. Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes

    1. Wioletta Rut
    2. Mikołaj Żmudziński
    3. Scott J. Snipas
    4. Miklos Bekes
    5. Tony T. Huang
    6. Marcin Drag

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Structural and Functional Comparison of SARS-CoV-2-Spike Receptor Binding Domain Produced in Pichia pastoris and Mammalian Cells

    1. Argentinian AntiCovid Consortium
    2. Claudia R. Arbeitman
    3. Gabriela Auge
    4. Matías Blaustein
    5. Luis Bredeston
    6. Enrique S. Corapi
    7. Patricio O. Craig
    8. Leandro A. Cossio
    9. Liliana Dain
    10. Cecilia D’Alessio
    11. Fernanda Elias
    12. Natalia B. Fernández
    13. Javier Gasulla
    14. Natalia Gorojovsky
    15. Gustavo E. Gudesblat
    16. María G. Herrera
    17. Lorena I. Ibañez
    18. Tommy Idrovo
    19. Matías Iglesias Randon
    20. Laura Kamenetzky
    21. Alejandro D. Nadra
    22. Diego G. Noseda
    23. Carlos H. Paván
    24. María F. Pavan
    25. María F. Pignataro
    26. Ernesto Roman
    27. Lucas A. M. Ruberto
    28. Natalia Rubinstein
    29. Javier Santos
    30. Francisco Velazquez Duarte
    31. Alicia M. Zelada

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    4 evaluationsAppears in 2 listsLatest version Latest activity

  9. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration

    1. Qi Yang
    2. Thomas A Hughes
    3. Anju Kelkar
    4. Xinheng Yu
    5. Kai Cheng
    6. Sheldon Park
    7. Wei-Chiao Huang
    8. Jonathan F Lovell
    9. Sriram Neelamegham

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation

    1. Tzu-Jing Yang
    2. Pei-Yu Yu
    3. Yuan-Chih Chang
    4. Shang-Te Danny Hsu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 78 of 93 Next